Cornelia Ahumada-Fuentes

Hospital Central Dr. Ignacio Morones Prieto
San Luis Potosi, SLP, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo.

DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo.

Journal: BioMed research international

Published: September 10, 2018

Physiometabolic effects of Agave salmiana fructans evaluated in Wistar rats.

Physiometabolic effects of Agave salmiana fructans evaluated in Wistar rats.

Journal: International journal of biological macromolecules

Published: September 11, 2017

Repigmentation patterns induced by NB-UVB and their relationship with melanocytic migration and proliferation in vitiligo.

Repigmentation patterns induced by NB-UVB and their relationship with melanocytic migration and proliferation in vitiligo.

Journal: Photodermatology, photoimmunology & photomedicine

Published: September 07, 2016

Relationship between transient receptor potential vanilloid-1 expression and the intensity of sensitive skin symptoms.

Relationship between transient receptor potential vanilloid-1 expression and the intensity of sensitive skin symptoms.

Journal: Journal of cosmetic dermatology

Published: November 22, 2015

CD4, IL-17, and COX-2 Are Associated With Subclinical Inflammation in Malar Melasma.

CD4, IL-17, and COX-2 Are Associated With Subclinical Inflammation in Malar Melasma.

Journal: The American Journal of dermatopathology

Published: September 19, 2015

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism.

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism.

Journal: Annals of clinical and translational neurology

Published: November 15, 2013

Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial.

Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial.

Journal: Photodermatology, photoimmunology & photomedicine

Published: November 01, 2013

Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study.

Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study.

Journal: Clinical, cosmetic and investigational dermatology

Published: January 29, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026